A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of this study is to assess levels in blood plasma of BMS-986278 and the food effect in healthy participants.

Key facts

Study ID

NCT04468815

Run by

Bristol-Myers Squibb

People needed

24

Starts

2020-07-10

Expected to finish

2020-10-07

Last updated by the study team

2022-05-10

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy participants, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations in the opinion of the investigator
• Women and men must agree to follow specific methods of contraception

You may not qualify if…

• Women of childbearing potential (WOCBP) and Women who are pregnant or breastfeeding
• Any significant acute or chronic medical condition that presents a potential risk to the participant and/or that may compromise the objectives of the study
• Exposure to any investigational drug or placebo within 4 weeks of first study treatment administration.
• History of any significant drug and/or food allergies (such as anaphylaxis or hepatotoxicity)
• Other protocol-defined inclusion/exclusion criteria apply

Where it is running

• ICON (LPRA) - Salt Lake — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.